Evidence map›Paper›PMID 39580489›Full record

ArticleScientific reports2024

Association of serum HIF-1α levels with coronary artery calcification in patients of non-dialysis chronic kidney disease.

Congcong Qin, Zhijuan Hu, Yanan Shi, Haowen Wu, Jingyu Ma, Jing Li

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Congcong QinDepartment of Nephrology, Hebei General Hospital, Xinhua District, No. 348, Heping West Road, Shijiazhuang, 050000, Hebei, China.
Zhijuan HuDepartment of Nephrology, Hebei General Hospital, Xinhua District, No. 348, Heping West Road, Shijiazhuang, 050000, Hebei, China. huzhijuan1972@163.com.
Yanan ShiDepartment of Nephrology, Hebei General Hospital, Xinhua District, No. 348, Heping West Road, Shijiazhuang, 050000, Hebei, China.
Haowen WuDepartment of Nephrology, Hebei General Hospital, Xinhua District, No. 348, Heping West Road, Shijiazhuang, 050000, Hebei, China.
Jingyu MaDepartment of Nephrology, Hebei General Hospital, Xinhua District, No. 348, Heping West Road, Shijiazhuang, 050000, Hebei, China.
Jing LiDepartment of Nephrology, Hebei General Hospital, Xinhua District, No. 348, Heping West Road, Shijiazhuang, 050000, Hebei, China.

Funding

Health Commission of Hebei Province 20211515
6 · The paper itself

Abstract

Vascular calcification is the main cause of death in patients with chronic kidney disease (CKD). The study aims to investigate the risk factor affecting coronary artery calcification (CAC), and the relationship between serum hypoxia-inducible factor-1α (HIF-1α) levels and CAC in non-dialysis CKD patients. One hundred and twenty-three patients were selected in the final analysis. Spearman rank correlation analysis assessed the correlation between HIF-1α levels and CAC scores. Logistic regression analysis was utilized to assess potential risk variables associated with CAC. A ROC curve was drawn to analyze the diagnostic value of HIF-1α in non-dialysis CKD patients with CAC. Compared to the non-CAC group, the CAC group was older age, with a higher proportion of males, smokers, hypertension and diabetes, lower eGFR and HDL-C, and higher SBP and HIF-1α levels. As the HIF-1α levels went up, the proportion of patients with VC increased, as well as Agatston scores. Spearman rank correlation analysis showed that HIF-1α levels were positively correlated with VC and Agatston scores. Logistic regression analysis indicated that being male (OR = 0.242, P = 0.036), older age (OR = 1.093, P < 0.001), and increased HIF-1α levels (OR = 1.002, P = 0.025) were risk factors for the occurrence of CAC. Furthermore, ROC curve analysis determined that a HIF-1α cutoff value of 451.177 pg·mL

Indexed as

Coronary Artery DiseaseHypoxia-Inducible Factor 1, alpha SubunitRenal Insufficiency, ChronicVascular CalcificationAgedFemaleHumansMaleMiddle AgedRisk FactorsROC CurveHIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitCoronary artery calcificationGenderHypoxia-inducible factor-1αNon-dialysis chronic kidney diseaseProlyl hydroxylase inhibitor

Identifiers

PMID39580489
PMCPMC11585538

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.